ARCHIVES

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

In Brief: Schmidt Asks NCI Grantees, Contractors To tell Him How They Waste Cancer Money

December 13, 1974

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training

June 20, 1986

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S.

July 31, 1998